Laboratory Question for the Week of June 14, 2021

Laboratory Compliance Question of the Week

Question:

What is the intent behind U0002? Is it true that it is reportable for in-house developed tests?

Answer:

HCPCS U0002 allows laboratories and healthcare facilities to bill CMS for validated, in-house developed COVID-19 tests. By code definition, the test must detect multiple types or subtypes; it should not be used for CDC.

U0002 2019-nCoV Coronavirus, SARSCoV- 2/2019-nCoV (COVID-19), any technique, multiple types or subtypes (includes all targets), non-CDC

This question was answered in an edition of our Laboratory Compliance Manager. For more hot topics relating to laboratory services, please visit our store or call us at 1.800.252.1578, ext. 2.

Disclaimer: Every reasonable effort was made to ensure the accuracy of this information at the time it was published. However, due to the nature of industry changes over time we cannot guarantee its validity after the year it was published.